These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Modulating amyloid-β aggregation: The effects of peptoid side chain placement and chirality. Turner JP; Chastain SE; Park D; Moss MA; Servoss SL Bioorg Med Chem; 2017 Jan; 25(1):20-26. PubMed ID: 27776890 [TBL] [Abstract][Full Text] [Related]
6. NSAIDs as potential treatment option for preventing amyloid β toxicity in Alzheimer's disease: an investigation by docking, molecular dynamics, and DFT studies. Azam F; Alabdullah NH; Ehmedat HM; Abulifa AR; Taban I; Upadhyayula S J Biomol Struct Dyn; 2018 Jun; 36(8):2099-2117. PubMed ID: 28571516 [TBL] [Abstract][Full Text] [Related]
7. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds. Dong M; Zhao W; Hu D; Ai H; Kang B ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293 [TBL] [Abstract][Full Text] [Related]
10. Amphiphilic Distyrylbenzene Derivatives as Potential Therapeutic and Imaging Agents for Soluble and Insoluble Amyloid β Aggregates in Alzheimer's Disease. Sun L; Cho HJ; Sen S; Arango AS; Huynh TT; Huang Y; Bandara N; Rogers BE; Tajkhorshid E; Mirica LM J Am Chem Soc; 2021 Jul; 143(27):10462-10476. PubMed ID: 34213901 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro. Wei CW; Peng Y; Zhang L; Huang Q; Cheng M; Liu YN; Li J Bioorg Med Chem Lett; 2011 Oct; 21(19):5818-21. PubMed ID: 21855336 [TBL] [Abstract][Full Text] [Related]
13. Testing synthetic amyloid-β aggregation inhibitor using single molecule atomic force spectroscopy. Hane FT; Lee BY; Petoyan A; Rauk A; Leonenko Z Biosens Bioelectron; 2014 Apr; 54():492-8. PubMed ID: 24321883 [TBL] [Abstract][Full Text] [Related]
14. Destabilization of β-amyloid aggregates by thrombin derived peptide: plausible role of thrombin in neuroprotection. De D; Bhattacharjee P; Das H; Kumar KS; Biswas SC; Bhattacharyya D FEBS J; 2020 Jun; 287(11):2386-2413. PubMed ID: 31747135 [TBL] [Abstract][Full Text] [Related]
15. Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. Antzutkin ON; Leapman RD; Balbach JJ; Tycko R Biochemistry; 2002 Dec; 41(51):15436-50. PubMed ID: 12484785 [TBL] [Abstract][Full Text] [Related]
16. Genistein: A Dual Inhibitor of Both Amyloid β and Human Islet Amylin Peptides. Ren B; Liu Y; Zhang Y; Cai Y; Gong X; Chang Y; Xu L; Zheng J ACS Chem Neurosci; 2018 May; 9(5):1215-1224. PubMed ID: 29432676 [TBL] [Abstract][Full Text] [Related]
17. Anthocyanin suppresses the toxicity of Aβ deposits through diversion of molecular forms in in vitro and in vivo models of Alzheimer's disease. Yamakawa MY; Uchino K; Watanabe Y; Adachi T; Nakanishi M; Ichino H; Hongo K; Mizobata T; Kobayashi S; Nakashima K; Kawata Y Nutr Neurosci; 2016; 19(1):32-42. PubMed ID: 26304685 [TBL] [Abstract][Full Text] [Related]
18. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation. Takahashi T; Mihara H Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396 [TBL] [Abstract][Full Text] [Related]
19. Molecular Design for Dual Modulation Effect of Amyloid Protein Aggregation. Zhu L; Song Y; Cheng PN; Moore JS J Am Chem Soc; 2015 Jul; 137(25):8062-8. PubMed ID: 26043045 [TBL] [Abstract][Full Text] [Related]
20. NABi, a novel β-sheet breaker, inhibits Aβ aggregation and neuronal toxicity: Therapeutic implications for Alzheimer's disease. Jang JY; Rhim H; Kang S Biochim Biophys Acta Gen Subj; 2018 Jan; 1862(1):71-80. PubMed ID: 29107146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]